November 18, 2026
Health news, explained with evidence
LIVE
Preventive Services Task Force Resumes Meetings Under New Leadership Blood-Based Genetic Signature May Predict CAR T-Cell Therapy Success in Lymphoma Ultraprocessed Diets May Impact Brain Reward Systems in Younger Adults Addressing Body Image and the Reality of Gluteal Anatomy Migraine and Smoking Linked to Increased Early Stroke Risk in Women CBD Oil Found Ineffective for Managing Behavioral Issues in Youths with Intellectual Disabilities Expert Advice on Hydration Gear Sparks Debate Among Recreational Runners A Structured Approach to Beginning a Strength and Cardio Routine The Role of Daily Mobility Training in Managing Sedentary Tension New Theoretical Framework Explores Memory Formation and Dementia Preventive Services Task Force Resumes Meetings Under New Leadership Blood-Based Genetic Signature May Predict CAR T-Cell Therapy Success in Lymphoma Ultraprocessed Diets May Impact Brain Reward Systems in Younger Adults Addressing Body Image and the Reality of Gluteal Anatomy Migraine and Smoking Linked to Increased Early Stroke Risk in Women CBD Oil Found Ineffective for Managing Behavioral Issues in Youths with Intellectual Disabilities Expert Advice on Hydration Gear Sparks Debate Among Recreational Runners A Structured Approach to Beginning a Strength and Cardio Routine The Role of Daily Mobility Training in Managing Sedentary Tension New Theoretical Framework Explores Memory Formation and Dementia

Blood Protein Signatures Linked to Cognitive Decline in Parkinson’s Disease

🧠 Mind & Mental Health 2 min read 👁 1

Researchers have identified specific plasma proteins, including key lysosomal proteases, linked to cognitive impairment and brain atrophy in Parkinson's disease. The preliminary findings offer potential pathways for predicting future cognitive deterioration.

🧠Mind & Mental Health

Key points

  • Researchers identified 284 plasma proteins that differentiated Parkinson's patients from healthy controls.
  • Elevated levels of lysosomal proteins CTSD, CTSZ, and CST3 were replicated across datasets and tied to cognitive and motor decline.
  • An exploratory combined clinical-proteomic model showed preliminary potential to forecast future cognitive loss (R² = 0.365).

A study led by French researchers, including teams from INSERM and AP-HP Hôpital Henri Mondor, has identified specific plasma protein signatures associated with cognitive impairment and regional brain atrophy in Parkinson’s disease. Analyzing longitudinal blood samples from the Parkinson’s Progression Markers Initiative—comprising 199 samples from 68 Parkinson’s patients and 345 samples from 115 healthy controls—the team identified 284 proteins that distinguished individuals with Parkinson's from controls with an area under the curve (AUC) of 0.88.

To confirm their results, the investigators cross-sectionally validated the findings using data from the Parkinson’s Disease Biomarkers Program, which involved 175 Parkinson’s patients and 17 healthy controls. Three lysosomal proteins—Cathepsin D (CTSD), Cathepsin Z (CTSZ), and Cystatin C (CST3)—replicated across platforms. Elevated levels of these proteases correlated with both motor dysfunction and cognitive impairment. In an exploratory model combining clinical data with proteomic measurements, the researchers demonstrated a preliminary ability to forecast longitudinal cognitive decline in a held-out patient subset (R² = 0.365).

What to know: Cognitive impairment represents a major source of disability for people living with Parkinson's disease, yet reliable blood-based biomarkers to track progression have remained limited. This observational research suggests that lysosomal protease dysfunction may contribute to cognitive vulnerability. However, the study relies on observational datasets and preliminary predictive modeling, meaning further research is required before these markers can be used in clinical practice. Individuals with questions about Parkinson's disease or cognitive symptoms should consult a medical professional for individual health guidance.

Source Nature Health Sciences — nature.com/articles/s41531-026-01612-4 ↗

Contact the newsroom

Got a tip, a proposal or a partnership question? Write to us and we will reply shortly.